EU Has banned marketing of around 700 generic drugs drugs. It may result in loss of exports for Indian Pharma Companies to the tune of 120 crore US Dollars. Mr. P. K. Appaji director general of pharma exports council of India has termed the ban unjustified and has said that it will affect the whole pharma sector in india.
It is to be noticed that EU has taken this step to prevent manipulation of data trials conducted by Indian pharma company G.V.K. Biosciences.